Human serum neuron-specific enolase (NSE) is a marker of neurons and of small-cell carcinoma of the lung; improved immunoassays of NSE remain an important goal. Here, we used overlapping complementary DNA (cDNA) clones for reconstruction to express full-length recombinant NSE, and also to express a set of cloned subfragments through the prokaryotic expression vectors pUEX and pUBEX. Subfragments expressed as fusion proteins were used to characterize immunogenic and antigenic regions and epitopes and, expressed as affinity matrices, to derive purified, fractionated polyclonalantibodies. NSE epitope data can be visualized with yeast enolase-1 crystal structure coordinates: The two protein sequences align almost perfectly and are 61% identical. This approach demonstrates the complementarity of cDNA expression with techniques of polyclonal antiserum and monoclonal antibody production and with chemical peptide synthesis in the refinement of immunodiagnostic reagents. .g., ref. 20) . On the assumption that the y subunit in a'' dimers reacts identically with that in yy dimers, these assays could be used to calculate total y subunit. More recently, F(ab')2 fragments immobilized on a solid phase were used to prepare two-site assays for yy and ay dimers (21) and to measure the amounts of home-and heterodimers in vivo in single isolated cerebellar Purkinje cells (22). Combinations of F(ab') fragments and monoclonal antibodies have also been tested (23), the greatest sensitivity being obtained with the polyclonal two-site format. Several monoclonal antibodies have now been raised and used to prepare immunometric assays in several formats (23-26). A two-site assay with a single monoclonal antibody, H14, measures solely the yy homodimer (24); pairwise combinations of antibodies E17, E19, and E21 (2.5) create assays having similar calibration curves for the yy dimer but markedly different curves for the ay dimer and different apparent concentrations in SCLC patients' sera, pre-
cDNA Reconstruction and Shotgun Subcloning
Overlapping partial eDNA clones described previously (5) were used. Unique restriction fragments were successively ligated via intermediate vector constructs (Fig. 1) to produce construct pQR1 (in pUC18). Radoning the insert into pUC19 (construct pQR2) into pUEX1 (28) (construct pQR3) and into pUBSEX (29) (construct pQR6) allowed in-frame recombinant expression of NSE with cloning junctions as listed in Table 1 . Constructs were verified by standard sequencing methods (30). The insert from pQR1 was used for shotgun cloning after self-ligation, sonication, and enzymatic repair as described (31); the random fragments were ligated into the polished PstI site of pUBSEX. The resulting clones were characterized both by sequencing and by immunoblotting (see below). In addition, some restriction fragments from pQR1 were used to clone specific regions (in their appropriate reading frames) into pUEX and derivative vectors for epitope mapping, again verified by restriction digests and (or) sequencing. (Fig. 3) , which are representative of major epitope regions designated El, E2, E3, and E4, respectively (Fig. 4) activity of antiserum with NSE, indicating that regions E1-4 appear to contain all of the major epitopes present in NSE. Affinity-purified fractions (readily obtainable by this method to preselected regions of NSE) were shown to function successfully as labeled second antibody in two-site assay formats (data not shown).
Expression and Characterization of Recombinant NSE

Discussion
Authenticity of Recombinant NSE
The reconstructed NSE eDNA was verified by restriction mapping and sequencing (including also the subsequent sequencing of many shotgun subclones), by sizing of the expressed NSE by PAGE with both large (pUEX) and small (PUBSEX) N-terminal lacZ fusion protein extensions, and by demonstrating the presence of an epitope for a monoclonal antibody (26) raised against a synthetic peptide at the C terminus of NSE, as well as its strong reactivity with polyclonal antisera raised against native NSE. domain of -130 amino acids and an eight-folds aJ/3 barrel (27) of -300 amino acids. The eight $ strands at the core of the barrel constitutethe cavity containing the active site. Region El falls in the N-terminal domain and regions E2-E4 fall on the ctI$ barrel. Region El spans from the first third of the first major loop to the end of the second a helixand is on the face of the subunit away from that of the subunit interface of the native dimer. El gave the strongest positive signal of any epitope region. Within El, clones 4 and 8 ( Fig. 3) suggest either that a single epitope is expressed in the loop between the first two a helices, or that these helices both contain major epitopes.
Regions E2 and E3 are centered at the two major loop regions of the a$ barrel. Clones 16 and 11 (Fig. 3) , which do not overlap but do react strongly in immunoblots, provide evidence that at least two epitope regions are present, designated E2 and E3 here. Clones 13 and 18 react weakly, providing further evidence for distinction of E2 and E3, whereas clone 20 localizes at least one strong epit.ope to the major loop contained within E3. Loop domains and other mobile exposed hydrophilic regions are known to form strong antigenic and immunogenic regions in other proteins, as shown by a variety of different experimental approaches (38) (39) (40) (41) , and typical linear epitopes are estimated to be six amino acids long. The emergent data from recombinant NSE fit the pattern for exposed and hydrophilicregions; however, the antigemc regions defined may each contain more than one major epitope. Region E4 extends through the eighth $ strand, the short loop, the eighth a-helix, and the C-terminal tail. Interestingly, the major epitope may reside in the last a-helix rather than the adjacent regions; however,subdivisionof the epitope region seems to result in loss of reactivity (compare clones 26, 25, and 24), perhaps suggesting a loss of secondary structure or steric interference in the shortest subclones.
Application of Epitope Region Map
Protein isolated from clones representing El, E2, E3, and E4 has been used to affinity-fractionate polyclonal antisera, thus circumventing one difficulty inherent in classical polyclonal two-site assays (42, 43), i.e., separating two antigenic or immunogenic regions that represent a single polypeptide moiety.
Although random monoclonal antibody generation (44) and syntheticpeptide immunizations can now achieve the objectives of two-site assays, the bulk of the polyclonal response is of low-affinity monoclonal antibodiesrather than high-affinity antibodies, making the latter therefore difficult to isolate. The polyclonal fractions should, however, contain high-affinity components and, with the techniques used here, can be purified for suitable use as labeled second antibodies.Synthetic peptides can be used to achieve similar formats (see, e.g., 45), but larger peptides, higher yields, lower costs, and flexibility of experimental design are advantages of the recombinant DNA methodologr.
The shotgun clones have also been used for de novo mapping of a monoclonal antibody epitope (46) and could be used to categorizeother epitopes to identify improved combinations for construction of assays and to identify antibodiesof potential interest for enzyme studies. Expression of recombinant antigens (47) and of recombinant antibodies (48) has been reviewed. The facilities of the former, illustrated here for human NSE, add a further facet to polyclonal and monoclonal antibody technologiesand should lead to new combinations of the two for use in immunoquantitation.
